Story perspectives

Nucleus Acquires Cambrean to Revolutionize AI Health Tech

2/1/2025

39 3

Summary

Story summary

Nucleus, a pioneering health tech company from the US, has made waves by acquiring Cambrean, an innovative AI health platform based in Cork. This strategic move will merge DNA insights with wearable data, paving the way for tailored health recommendations. Following a successful $14M Series A funding round, Nucleus has now raised a total of $32M since its inception in 2021, striving to democratize whole-genome sequencing and tackle chronic disease risks.

1 of 1

Story summary

Nucleus, a pioneering health tech company from the US, has made waves by acquiring Cambrean, an innovative AI health platform based in Cork. This strategic move will merge DNA insights with wearable data, paving the way for tailored health recommendations. Following a successful $14M Series A funding round, Nucleus has now raised a total of $32M since its inception in 2021, striving to democratize whole-genome sequencing and tackle chronic disease risks.